K

Kiniksa Pharmaceuticals Ltd
D

KNSA

38.470
USD
1.01
(2.70%)
مغلق
حجم التداول
25,239
الربح لكل سهم
0
العائد الربحي
-
P/E
769
حجم السوق
2,850,921,988
أصول ذات صلة الأخبار المقالات

العنوان: Kiniksa Pharmaceuticals International plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.